I-ASMARCAP kunye ne-GAAPP isicelo senkxaso kwizigulana ze-asthma eNigeria
20/12/2023
20/12/2023
IGlobal Allergy & Airways Patient Patient (I-GAAPP), iProjekthi yePhulo lokuNcedisa uMbefu (ASMARCAP), kulandela yamva nje Ingqungquthela yeHlabathi yokuphefumla Ngo-2023 eMilan, ufuna ukuzisa ingqwalasela kwimingeni ejongene nayo izigulana zombefu eNigeria ukususela ngoku GlaxoSmithKline's ukurhoxa kweli lizwe.
GSK Ventolin I-inhalers ibe iyeza lokuqala loncedo lokuqala I-95% yezigulane ze-asthma eNigeria. Ukusukela ekumkeni kwe-GSK eNigeria, iindleko ze ezi inhalers ziye zanyuka ukusuka kwi-2000 Naira ukuya kwi-10,000 yeNaira nangaphezulu, ebathwalisa nzima abo bachaphazelekayo. Umbefu sisifo esixhaphakileyo esichaphazela izigidi zabantu, kuquka nabantwana abasahamba isikolo. Imfundo eyiyo malunga nesifuba somoya ibaxhobisa ukuba baphile ubomi obusempilweni kwaye idala indawo ekhuselekileyo, nenolwazi ngakumbi esikolweni.
Ngenxa yezi meko, singathanda ukucela oku kulandelayo:
Unokukhuphela ileta epheleleyo ngesiNgesi:
ukuba unayo nayiphi na imibuzo, zive ukhululekile ukuqhagamshelana nathi info@gaapp.org okanye usitsalele umnxeba ku (+43) 6767534200